-
- Posts: 5
- Joined: Thu Jan 31, 2008 11:40 am
There is a long time since last time I logged in.
Now, i would be very grateful if some one could help me in the following aspect.
I work with Therapeutic drug Monitoring, in a validated method for the determination of antiretroviral agents.
Initially, the method was validated for heparinized plasma as matrix, but, now, and in order to benefit some patients whom we have plasma EDTA, and to avoid a new boold extraction; we use this plasma to quantitate.
Previously, we have passed a quintuplicate of the three levels in plasma EDTA of quality control to calculate the RSD.
Is that OK?
Have we to do another thing else?
Could someone help me?
Thank you very much
Anna
